Fig. 2

Erectile response (ICP/MAP) AUC (a), amplitude (b), duration (c), front slope (d), latency (e) and time to maximum (f), bulbocavernosus muscle EMG AUC (g), frequency (h) and duration (i) in control rats (CNTL, n = 8), animals with surgically (cavernous nerve crush, CnX, n = 8) or pharmacologically (trimetaphan administration, TMPh, n = 7) abolished erectile response, rats with surgically (motor branch of the pudendal nerve crush, PnX, n = 8) or pharmacologically (d-tubokurarine administration, dTK, n = 8) abolished perineal muscles activity, or after sensory dorsal penile nerve crush (DPnX, n = 7). The data are presented as percent of baseline (before the treatment) values. $ - p < 0.05 vs. control, # - p < 0.05 vs. baseline, Sidak’s post-test